Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 808 results for "novartis ag"

Novartis could face South Korea sales ban amid corruption alle...

Swiss pharmaceutical giant Novartis risks seeing some of its medicines banned in South Korea after company executives were charged with offering illegal discounts to doctors, the Financial Times reported on Thursday. Posted 12 Aug 2016 01:43 ... Channel NewsAsia, 2 weeks ago

67 images for novartis ag

Bidness Etc, 3 days ago
biospace.com, 2 weeks ago
Share Market Updates, 4 days ago
SRN News, 4 days ago
Bidness Etc, 3 days ago
Bidness Etc, 1 month ago
CTV News, 1 month ago
Bidness Etc, 1 month ago
CTV News, 1 month ago
Domain-B, 1 month ago

SC 13D/A - NOVARTIS AG (0001114448) (Filed by)

Filed: 2016-08-10 AccNo: 0001104659-16-138659
 SEC Filings2 weeks ago
Bidness Etc

Novartis Ready to Launch Game Changer Molecule for Asthma Treatment

With the launch of the inhaled powder disks for the prevention of the asthmatic attacks, the prevalence of the disease still remains the same. Approximately 3,600 patients die annually in the US from multiple ailments related to asthma and chronic ...
 Bidness Etc2 weeks ago New Novartis Asthma Pill Shows Promise  Nasdaq3 weeks ago Novartis AG's New Asthma Drug Hailed a Game-Changer After Success in Small Trial  BioSpace3 weeks ago

Novartis pill gets U.S. breakthrough designation in breast cancer

ZURICH, Aug 3 (Reuters) - Novartis AG breast cancer pill LEE011 has won breakthrough therapy designation from U.S. regulators as a first-line treatment for a form of advanced breast cancer, the Swiss drugmaker said on Wednesday. The Food and Drug ...
 Yahoo! Finance3 weeks ago
Nasdaq

Stada Arzneimittel Braced for Investor Battle

Novartis (NYSE:NVS) Intraday Stock Chart Today : Monday 15 August 2016 FRANKFURT—Germany is gearing up for a rare proxy fight between activist investors and a company's incumbent management with pressure mounting on the board of generic ...
 ADVFN India2 weeks ago AbbVie Sues Amgen Over Humira  ADVFN UK3 weeks ago ABBVIE : Files Patent Suit Over Amgen's Copy of Humira  4 Traders3 weeks ago AbbVie Sues Amgen Over Humira -- WSJ  4 Traders3 weeks ago
[x]  
EuroInvestor

NOVARTIS : Six leading scientists to receive prestigious Novartis Prizes for Immunology at 16th International Congress of Immunology

Novartis International AG / Six leading scientists to receive prestigious Novartis Prizes for Immunology at 16th International Congress of Immunology . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible ...
 4 Traders2 weeks ago Six leading scientists to receive prestigious Novartis Prizes for Immunology at 16th International Congress of Immunology  AndhraNews.net2 weeks ago FDA Bestows Novartis AG's Breast Cancer Pill With Breakthrough Tag  BioSpace3 weeks ago NOVARTIS : CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therapy designation as first-line treatment for HR+/HER2- advanced breast cancer  4 Traders3 weeks ago
[x]  

Novartis executives indicted for illegal rebates

SEOUL, Aug. 11 (Yonhap) -- Six incumbent and former executives of the South Korean unit of Swiss pharmaceutical giant Novartis have been indicted on charges of providing illegal kickbacks to doctors, industry sources said Thursday. Earlier this ...
 Yonhap News Agency2 weeks ago

Pricing dispute hits supply of TB drugs in Pakistan

ISLAMABAD (Reuters) - Swiss pharmaceuticals firm Novartis AG said it has stopped making tuberculosis drugs in Pakistan in a dispute over pricing, prompting fears of a health crisis due to a shortage of drugs in a country with the world's fifth-highest TB ...
 Reuters1 month ago

Novartis announces positive phase III results for MS drug siponimod

Novartis AG said a late-stage study showed its oral, once-daily BAF312, or siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis. The Phase III EXPAND study, the largest randomized, controlled study in secondary ...
 Reuters5 days ago

MUFG Americas Holdings Corp Reduces Stake in Novartis AG (NVS)

MUFG Americas Holdings Corp cut its position in Novartis AG (NYSE:NVS) by 3.3% during the second quarter, Holdings Channel reports. The fund owned 46,725 shares of the company's stock after selling 1,595 shares during the period. MUFG Americas ...
 Ticker Report2 weeks ago Banced Corp Purchases 403 Shares of Novartis AG (NVS)  WKRB News2 weeks ago Novartis AG (NVS) Position Reduced by Patton Albertson Miller Group LLC  Newstex.ACI.info2 weeks ago Novartis AG (NVS) Shares Bought by DAVENPORT & Co LLC  Zolmax News2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis ag
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less